YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Divis Labs
Divis Labs
BSE: 532488NSE: DIVISLABISIN: INE361B01024

23rd-Oct-2020 14:06Source: BSE

Divis Laboratories - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

We have earlier informed vide our letter dated 02 July, 2020 that SEBI has passed an Impounding Order cum Show Cause notice bearing no. WTM/GM/IVD/14/2020-21 dated 01 July, 2020 against Mr. L. Kishore Babu, Chief Financial Officer of the Company and others (Noticees).

The Noticees filed settlement application(s) before SEBI under the SEBI (Settlement Proceedings) Regulations, 2018 in respect of the said proceedings, to settle without admitting or denying the findings of fact and conclusions of law.

SEBI, on the Noticees complying with the terms of the proposal for settlement, has passed a Settlement Order vide ref. no. SO/EFD-2/SD /356/OCTOBER/2020 dated 21 October, 2020 settling the enforcement proceedings against Noticees.

This is for your information and records.

Sections